Burn Injuries During COVID-19 Pandemic and Its Influence on Length of Stay
Conditions: SARS-CoV-2 Infection Interventions: Procedure: Burn Injuries Graft Surgery Sponsors: Hamad Medical Corporation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Diabetic Patients
Conditions: Comprehensive Complication Index Interventions: Device: Continuous glucose monitoring (CGM) device Sponsors: Beijing Tsinghua Chang Gung Hospital; Peking University International Hospital; Wang Jing Hospital; ZhuHai Hospital; Beijing Hospital; Siyang County Hospital of Traditional Chinese Medicine; Second Hospital of Shanxi Medical University; Henan Provincial Chest Hospital; Fuzhou First Hospital; Pinggu Hospital of Beijing Traditional Chinese Medicine Hospital; The First Affiliated Hospital of Anhui University of Chinese Medicine; The First Affiliated Hospital of Zhengzhou University; Mindong Hospital of Ning...
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Diaphragmatic Breathing Exercises for Post-COVID-19 Diaphragmatic Dysfunction (DD)
Conditions: Post-Acute Sequelae of COVID-19 Interventions: Other: Usual care of traditional treatment; Other: Specific DB program/Diaphragmatic manipulation program Sponsors: University of Minnesota Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
A Cross-Sectional Analysis of Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria
Conditions: Musculoskeletal Pain; COVID-19 Sponsors: Syrian Private University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria
Conditions: Musculoskeletal Pain; COVID-19 Sponsors: Syrian Private University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Invivyd Announces FDA Authorization for Emergency Use of Pemgarda (Formerly VYD222) for Pre-Exposure Prophylaxis (PrEP) of COVID-19
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that Pemgarda™ (pemivibart), formerly... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 22, 2024 Category: Pharmaceuticals Source Type: clinical trials
Research on Precision Pharmaceutical Care for Heart Transplant Recipients
Conditions: Heart Transplant Patients Sponsors: Nanjing First Hospital, Nanjing Medical University; Wuhan Union Hospital, China; Changhai Hospital; Shanghai Zhongshan Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Model to Predict Coinfection in Elderly Patients With COVID-19
Conditions: Covid19 Sponsors: Xiangya Hospital of Central South University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
Conditions: Portal Vein Thrombosis Interventions: Procedure: TIPS; Drug: Nadroparin Sponsors: Shanghai Zhongshan Hospital; Shanghai 6th People ' s Hospital; Shanghai Shuguang Hospital; Tongji Hospital affiliated to Tongji University; People ' s hospital affiliated to Wuhan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Conditions: PASC Post Acute Sequelae of COVID 19; Long COVID Interventions: Drug: 1500 Valacyclovir 200 Celecoxib; Drug: 750 Valacyclovir 200 Celecoxib; Drug: Placebo Sponsors: Bateman Horne Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19
Conditions: SARS-CoV-2 Infection Interventions: Diagnostic Test: lung function testing Sponsors: University of Rostock Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 Infection
Conditions: Breast Cancer; COVID-19; Postoperative Complications Interventions: Other: Preoperative resolved COVID-19 Sponsors: Fujian Medical University Union Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Conditions: Safety; Effective Interventions: Drug: RD06-04 Cells injection Sponsors: Wuhan Union Hospital, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19
Conditions: Long COVID Interventions: Diagnostic Test: RNA Biomarker Blood Test Sponsors: MaxWell Clinic, PLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer: From a Multicenter Phase II Cohort to a Phase III Randomized Controlled Study
Conditions: Locally Advanced Rectal Carcinoma Interventions: Drug: Tislelizumab Sponsors: Beijing Friendship Hospital; Beijing Chao Yang Hospital; Peking University Cancer Hospital& Institute; CHINA-JAPEN FRIENDSHIP HOSPITAL; Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Fudan University; Changhai Hospital; RenJi Hospital; Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine; Shandong Provincial Hospital; Zhongnan Hospital of Wuhan University& Second Clinical Hospital of Wuhan University; The First Affiliated Hospital of Zhengzhou...
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
